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Abstract
Background: Level of the testosterone in a man’s life span is very important. Studies on the serum testosterone
concentrations in different age groups of healthy men were controversial. The aim of this study was to investigate
dynamic changes of serum reproductive hormones with aging in healthy Chinese male and to compare its correlation
with age.
Methods: Total of 1,093 healthy Chinese men from Shanghai aged from 20 to 87 years old was enrolled in the study.
Concentrations of serum total testosterone (T), luteinizing hormone (LH) and sex hormone binding globulin (SHBG)
were quantified by EIA. Testosterone secretion index (TSI) and free testosterone index (FTI) were then calculated. Data
were analyzed by SPSS program. Non-parametric tests and univariate linear regression analyses were used.
Results: The 1,039 male participants were grouped into 12 groups by 5-year apart for each group. Significant differences
in T, LH, SHBG, FTI and TSI were found between the 12 different age groups. Average of serum total T was 15.36
± 4.86 nmol/L; LH was 4.76 ± 2.76 IU/L, SHBG was 32.61 ± 17.24 nmol/L. Compared to age 20 ~ 24 group, serum T
level of age 35 ~ 39, 40 ~ 44, 45 ~ 49, 50 ~ 54, and 55 ~ 59 was significantly decreased (p < 0.05). Intriguingly,
however, serum T level of age 60 or older did not significantly reduced compared to the age of 20 ~ 24 group. Serum
LH and SHBG were positively correlated with aging (p <0.01), while TSI and FTI were negatively correlated with aging
(p <0.01). In addition, BMI was negatively and significantly correlated with levels of T (r = −0.585, p < 0.001), LH
(r = −0.090, p < 0.001), SHBG (r = − 1.817, p < 0.001), and TSI (r = − 0.104, p < 0.001), but positively and significantly
correlated with FTI level (r = 0.011, p < 0.001).
Conclusion: Serum total testosterone fluctuated with aging in adult men, and FTI and TSI decreased gradually
with aging. While age was not significantly correlated with T level, BMI was significantly and negatively correlated
with T level, suggesting body weight may affect testosterone level.
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Introduction
Testosterone plays key roles in developing secondary
sexual characteristics, supporting spermatogenesis and
regulating libido in the male [1]. Low-serum testosterone
has been associated with numerous age-related adverse
health conditions including abdominal obesity, diabetes,
and pre-diabetic states (such as insulin resistance, im-
paired glucose tolerance, and metabolic syndrome),
dyslipidemia, low bone and muscle mass, impaired sex-
ual function, depressed mood, frailty, and decreased
quality of life [2, 3]. In this regard, obesity may contrib-
ute to low total testosterone levels that can be explained
at least partially by lower sex hormone-binding globulin
(SHBG) in obese men [4, 5].
The incidence of testosterone deficiency (TD)
increased with age due to decline in testosterone
production after age 30 [6, 7]. Testosterone supplemen-
tation therapy (TST), therefore, has now become one of
the most widely used medications in aged men with the
increasing proportion of the population > 65 years of age
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and the increasing incidence of medical comorbidities
associated with low testosterone, such as diabetes, meta-
bolic syndrome, cardiovascular disease and erection dys-
function [8, 9]. The incidence of TD in healthy, middle-
aged men has been reported as high as 6 %, and men in
the seventies of age have mean plasma testosterone
levels 35 % lower than that of young men [10–12]. Des-
pite increasing incidence of TD, diagnosis and treatment
of TD remains challenge for clinician because symptoms
of males with TD are nonspecific and variable, and thus,
only 12 % of clinically symptomatic, hypogonadal males
are successfully treated with TST [10, 13].
While level of the testosterone in men’s life span is
very important, decline of serum testosterone level in
healthy men may vary depending on ethnics, environ-
ment, and life style such as food. In this content, it has
been reported that total serum testosterone level was
significantly higher in Caucasians (aged 22–27 yr) from
the USA than that in Chinese (aged 24–39 yr) living in
Beijing, China [14]. Furthermore, serum level of total
testosterone in Chinese men from Pennsylvania (aged
20–37 yr) was also significantly higher than that of
Chinese living in Beijing, China, although it was lower
compared to that of Caucasians [14]. Similarly, Chinese
living in China had significantly lower serum SHBG level
compared to Chinese living in the USA [14].
Testosterone is produced by Leydig cells, which are
terminally differentiated cells, and is regulated by
luteinizing hormone (LH), which is synthesized and pro-
duced by the pituitary gland. Role of LH in regulating
serum testosterone concentration in human being remains
to be defined. In this regard, in the rodent aging models of
Sprague–Dawley rats, it was found that aging lead to de-
creased LH levels that resulted in reduced stimulation of
the Leydig cells [15]. In contrast to the rodent, it was
found that serum LH levels rose moderately or did not
change at all in older men even though declines in serum
testosterone occurred [10, 16, 17]. In the current study,
therefore, we investigated dynamic alteration of serum
total testosterone (T), luteinizing hormone (LH) and sex
hormone binding globulin (SHBG) in 1,093 healthy
Chinese men whose age was from 20 to 87 years old.
Testosterone secretion index (TSI) and free testosterone
index (FTI) were also calculated.
Materials and methods
Patients
The current study was designed as a cross-sectional and
single-center population-based observational study on
endocrine status in adult men. Total 1,513 men were
interviewed and 1,093 of them were finally enrolled in
the current study. The inclusion criteria were: 1). At
least 20 years old male; 2). No self-report of chronic ill-
ness (diabetes, high blood pressure, heart disease,
cancer); 3). No current prescription medication known
to affect the hypothalamic-pituitary-gonadal (HPG) axis
(including testosterone, anti-androgen, glucocorticoid,
opiate, antiepileptic, antipsychotics, 5-α reductase in-
hibitors, or aromatase inhibitors); 4). No genital
system surgery.
Consent to publish
This study was approved by The Institutional Review
Board of Ethics Committee of Shanghai Jiao Tong
University Affiliated Sixth People's Hospital. All par-
ticipants received written and oral information prior
to giving written consent, and the study was per-
formed in accordance with the Helsinki II declaration.
Sample collection
Blood sample was collected by venipuncture between 8
and 10 AM after an overnight fast of at least 8 h. After
centrifugation, serum was harvested and stored at −80 °C
until being processed.
Assays
Chemiluminescence method, a commercially available
diagnostic reagent kit and chemiluminescent analyzer,
was used to measure serum T and LH (Beckman Coulter
Inc, USA). Sensitivity of the assay was 0.01 nmol/L for
testosterone and 0.2 IU/L for LH; the intra-assay coeffi-
cient of variation (CV) was 3.93 % and 3.8 %, and the
inter-assay CV was 7.08 % and 6.4 %.
Serum SHBG level was determined by Two-step
Enzyme ImmunoAssay (Beckman Coulter Inc, USA).
The sensitivity was 0.2 nmol/L, intra-assay CV was
5.3 %, and inter-assay CV was <7 %. Diphosphoglycerate,
triglyceride, and total cholesterol were also measured.
Testosterone secretion index (TSI) was calculated as
testosterone divided by LH. Free testosterone index
(FTI) was calculated as testosterone divided by SHBG.
Body mass index was calculated as patient’s weight (kg)
divided by squared height (m2).
Statistical analysis
Data was verified and input into SPSS database, and was
analyzed with SPSS 21.0 statistical package. Non-
parametric tests were conducted in that all measured or
calculated parameters were in abnormal distribution
after normality test, even after logarithmic transform-
ation. The median was considered to represent average
level of the measured value, the 10th percentile and the
90th percentile represented the lower and upper limit of
the reference value. Mann-Whitney U test was used to
compare the sex steroids as well as correlation parame-
ters between the 12 age groups of each decade.
The association between sex steroids and age was
assessed by univariate linear regression analyses.
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Calculations were not adjusted for multiple compari-
sons as variables were correlated and all the tests
were performed in an exploratory manner. Calcula-
tions were performed using SPSS v21.0 with p values
< 0.05 considered significant.
Results
Characteristics of the study population
Total of 1,093 healthy males, who were 20 to 87 years
old, participated in the current study. They were divided
into 12 groups by 5-year of age apart. Of them, 20
participants were 20 ~ 24 years old; 185 were 25 ~ 29;
146 were 30 ~ 34; 101 were 35 ~ 39; 94 were 40 ~ 44; 65
were 45 ~ 49; 63 were 50 ~ 54; 87 were 55 ~ 59; 116 were
60 ~ 64; 92 were 65 ~ 69; 48 were 70 ~ 74; and 56 partici-
pants were 75 or older.
Dynamic alteration of serum reproductive hormones
Dynamic alteration of serum levels of T, LH, SHBG, and
calculated FTI and TSI was presented in Table 1. Aver-
age of total serum T was 15.36 ± 4.86 nmol/L (95 % CI:
15.07 ~ 15.65, n = 1093); LH was 4.76 ± 2.76 IU/L (95 % CI:
4.60 ~ 4.93), SHBG was 32.61 ± 17.24 nmol/L (95 % CI:
31.49 ~ 33.72), FTI was 0.55 ± 0.24 % (95 % CI: 0.53 ~ 0.56),
and TSI was 3.98 ± 2.01 nmol/IU (95 % CI: 3.86 ~ 4.10).
As shown in Table 1, compared to age 20 ~ 24 group
(n = 20, 17.3 ± 4.95 nmol/L), serum T level of age 35 ~
39 (n = 101, 14.40 ± 4.33 nmol/L), 40 ~ 44 (n = 94, 14.33
± 4.91 nmol/L), 45 ~ 49 (n = 65, 14.22 ± 4.17 nmol/L), 50
~ 54 (n = 63, 14.19 ± 3.93 nmol/L), and 55 ~ 59 (n = 87,
14.73 ± 4.87 nmol/L) was significantly decreased (p < 0.05).
Intriguingly, however, serum T level of age 60 or older did
not significantly reduced compared to the age of 20 ~ 24
group (p > 0. 05). In contrast, serum LH level of age
60 ~ 64 (n = 116, 6.10 ± 3.56 IU/L), 65 ~ 69 (6.33 ±
3.06 IU/L), 70 ~ 74 (6.87 ± 3.86 IU/L), 75 ~ (8.32 ±
4.19 IU/L) was significantly higher than that of age
20 ~ 24 (n = 40, 4.06 ± 1.73 IU/L, p < 0.05), while
serum LH level of age 25 ~ 49 was not significantly
increased compared to that of age 20 ~ 24 group (p >
0.05). Similar to LH, serum level of SHBG gradually
increased with aging and significantly higher from age
45 ~ compared to that of age 20 ~ 24 (p < 0.05). FTI
was significantly lower after 30 or older (p < 0.05) and
TSI decreased significantly with aging after 50 or
older (p < 0.05).
Serum testosterone gradually decreased till 35 years
old followed a plateau at age 35 ~ 50, and a slight in-
crease of serum T was observed between age of 50 ~
70 years old (Fig. 1a). Serum LH was low at younger age
groups (20 ~ 50 years old) followed by gradual increase
with aging, and reached a highest level at age of 75 or
older (Fig. 1b). Similarly, serum SHBG also gradually in-
creased with aging, reached highest at age of 75 or older
(Fig. 1c). In contrast, FTI and TSI were both gradually
decreased with aging (Fig. 2a and b, respectively).
Correlation analysis
The association between sex steroids and the participants’
basic features including age, body mass index (BMI),
diphosphoglycerate (BPG), triglyceride (TG), and total
cholesterol (TC) was assessed by Spearman rank correl-
ation analysis (Table 2). There was no significant correl-
ation between testosterone and age (r = − 0.013, p = 0.657)
or testosterone level and TC level (r = 0.249, p = 0.142).
However, LH and SHBG were positively correlated with
age (r = 0.422, 0.475,respectively, p < 0. 001), and in
contrast, FTI and TSI were negatively correlated with age
Table 1 Serum levels of hormones in chinese male at age 20 to 87
Age
group
Number Serum level, mean ± SD (95 % CI)
T (nmol/L) LH (IU/L) SHBG (nmol/L) FTI( % ) TSI (nmol/IU)
20~ 40 17.31 ± 4.95 (15.73,18.89) 4.06 ± 1.73 (3.51,4.61) 25.91 ± 10.39 (22.59,29.23) 0.73 ± 0.21 (0.66,0.80) 4.79 ± 1.91 (4.18,5.40)
25~ 185 16.18 ± 4.57 (15.52,16.85) 3.97 ± 1.73 (3.72,4.22) 25.44 ± 11.29 (23.80,27.08) 0.71 ± 0.27 (0.67,0.75) 4.65 ± 1.87 (4.38,4.92)
30~ 146 15.46 ± 4.59 (14.71,16.21) 3.76 ± 1.53 (3.51,4.01) 28.69 ± 15.74 (26.12,31.27) 0.62 ± 0.22* (0.59,0.66) 4.67 ± 2.18 (4.31,5.03)
35~ 101 14.40 ± 4.33* (13.54,15.25) 3.84 ± 1.35 (3.57,4.11) 26.77 ± 12.08 (24.39,29.16) 0.59 ± 0.20* (0.55,0.63) 4.17 ± 1.87 (3.80,4.54)
40~ 94 14.33 ± 4.91* (13.33,15.34) 3.79 ± 1.66 (3.45,4.13) 30.49 ± 14.11 (27.60,33.38) 0.51 ± 0.16* (0.48,0.55) 4.44 ± 2.40 (3.95,4.93)
45~ 65 14.22 ± 4.17* (13.18,15.25) 4.02 ± 1.95 (3.54,4.51) 32.90 ± 14.28* (29.36,36.44) 0.47 ± 0.13* (0.44,0.50) 4.19 ± 1.93 (3.71,4.66)
50~ 63 14.19 ± 3.93* (13.20,15.18) 4.28 ± 1.72 (3.85,4.71) 34.01 ± 13.66* (30.57,37.46) 0.46 ± 0.16* (0.42,0.50) 3.83 ± 1.78* (3.38,4.28)
55~ 87 14.73 ± 4.87* (13.69,15.77) 4.63 ± 2.67 (4.06,5.20) 38.18 ± 17.07* (34.54,41.82) 0.43 ± 0.14* (0.40,0.46) 3.78 ± 1.62* (3.43,4.12)
60~ 116 15.32 ± 4.81 (14.43,16.20) 6.10 ± 3.56* (5.44,6.75) 43.27 ± 17.44* (38.09,48.45) 0.35 ± 0.10* (0.32,0.38) 3.31 ± 1.90* (2.96,3.66)
65~ 92 16.18 ± 5.49 (15.05,17.32) 6.33 ± 3.06* (5.69,6.96) 45.19 ± 13.19* (40.36,50.03) 0.34 ± 0.06* (0.31,0.36) 3.08 ± 1.68* (2.73,3.43)
70~ 48 16.36 ± 6.23 (14.55,18.17) 6.87 ± 3.86* (5.75,7.99) 50.64 ± 25.84* (39.47,61.81) 0.34 ± 0.09* (0.30,0.38) 2.95 ± 1.58* (2.49,3.41)
75~ 56 15.96 ± 5.56 (14.47,17.45) 8.32 ± 4.19* (7.19,9.44) 60.64 ± 26.05* (52.07,69.20) 0.26 ± 0.09* (0.23,0.29) 2.31 ± 1.14* (2.00,2.61)
Total 1093 15.36 ± 4.86 (15.07,15.65) 4.76 ± 2.76* (4.60,4.93) 32.61 ± 17.24 (31.49,33.72) 0.55 ± 0.24* (0.53,0.56) 3.98 ± 2.01* (3.86,4.10)
*Compared to age group 20~, p < 0.05 by Mann–Whitney U test
Liu et al. Reproductive Biology and Endocrinology  (2015) 13:111 Page 3 of 7
(r = −0.342, −0.569,respectively, p < 0.001). Intriguingly,
BMI was inversely and significantly correlated with
levels of testosterone (r = −0.585, p < 0.001), LH (r = −0.090,
p < 0.001), SHBG (r= − 1.817, p < 0.001), and TSI (r = −
0.104, p < 0.001), but positively and significantly correlated
with FTI level (r = 0.011, p < 0.001). In addition, T and
SHBG were negatively and significantly correlated with TG
(p < 0.001), but not with TC (p > 0.05). FTI was significantly
correlated with TG (p < 0.001), but negatively correlated
with TC (p = 0.028).
Discussion
This study was designed to determine dynamic alteration
of testosterone in healthy Chinese male by a single-
center population-based cross-sectional study. Serum
level of total testosterone (T), luteinizing hormone (LH),
and sex hormone binding globulin (SHBG) were quanti-
fied. Testosterone secretion index (TSI) and free testos-
terone index (FTI) were then calculated based on total
T, LH and SHBG. It was found that average serum total
T concentration was 15.36 ± 4.86 nmol/L, LH was 4.76
± 2.76 IU/L, and SHBG was 32.61 ± 17.24 nmol/L. Cal-
culated mean FTI was 0.55 ± 0.24, and mean TSI was
3.98 ± 2.01 nmol/IU.
Testosterone is the major androgen in male, and
95 % testosterone is secreted by the Leydig cells and
5 % is secreted by the adrenal glands. Adult Leydig
cells are terminally differentiated cells, and secretion
of testosterone (T) by Leydig cells is regulated by
luteinizing hormone (LH), which is synthesized and
produced by the pituitary gland. The secretion of T is
regulated by the hypothalamic-pituitary-gonadal axis.
Fig. 1 Level of serum testosterone (T), luteinizing hormone (LH), and sex hormone binding globulin (SHBG) with aging. Serum concentration of
testosterone (Panel a), LH (Panel b), and SHBG (Panel c) were quantified as described in the method. Vertical axis: mean and 95 % CI; horizontal
axis: age groups by 5-year apart
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Approximately 98 % of circulating testosterone is
bound to plasma proteins, with the remaining 2 %
circulating freely.
Many studies have now demonstrated that as men aging,
their serum testosterone concentrations fall. These studies
include both cross-sectional and longitudinal studies. In
this context, in the Baltimore Longitudinal Study of Aging,
serum total testosterone concentration decreased modestly
with increasing age, and an index of the free testosterone
concentration decreased even more [18]. Longitudinal
observation in the Massachusetts Male Aging Study also
showed a decrease in total testosterone with increasing age
and a greater decrease in free testosterone [19]. Feldman
HA [20] reported that total T declined cross-sectionally at
0.8 %/yr of age, both free and albumin-bound T declined
at about 2 %/yr, sex hormone-binding globulin increased
cross-sectionally at 1.6 %/yr; that the longitudinal decline
in total T was 1.6 %/yr and bioavailable T was 2–3 %/yr.
The mechanisms of testosterone reduction with aging
seem to reflect changes at all levels of the hypothalamic-
pituitary-testicular axis [21]. In this regard, gonadotrophin
levels rose during aging [20] and testicular secretory re-
sponses to recombinant human chorionic gonadotrophin
(hCG) were reduced [22], which implies that reduced pro-
duction of testosterone may be caused by primary testicu-
lar failure. In addition, change in the lutenising hormone
(LH) production may also contribute to the reduction of
testosterone in aged population [22, 23].
In the current study, interestingly, level of the total
testosterone showed a decreasing tendency from age of
20 to 35 years old followed by a plateau at 35 ~ 50, and
then an increasing tendency after age of 50 and reached
highest at age 70. The LH was lower in the age of 20s
and 30s, followed by a gradual increase at 40s, and sig-
nificant increase after 50s, especially at 60s and 70s age
group. The SHBG showed an increase with aging, and in
contrast, FTI and TSI were reduced with aging. The ap-
pearance of plateau at age 35 ~ 50 and increasing ten-
dency after age of 50 in testosterone concentration was
unexpected. While the mechanism of this phenomenon
remains to be defined, it might attribute to the gradual
increase of LH after 40s, which was demonstrated in the
current study.
While many published data showed that serum testos-
terone decreased with aging [6, 24], studies also indicated
that serum total testosterone were not significantly altered
in aged population compared to young population. In this
context, Frost M [25] investigated 783 men aged 20–29
years and 600 men aged 60–74 years who were randomly
Fig. 2 Free testosterone index (FTI) and testosterone secretion index (TSI) with aging. FTI and TSI were calculated as described in the method and
presented in Panel a and Panel b, respectively. Vertical axes: mean and 95 % CI; horizontal axis: age groups by 5-year apart
Table 2 Correlations between basic features and levels of T, LH,
SHBG, FTI, and TSI in chinese male
Statistical value* T LH SHBG FTI TSI
Age r −0.039 0.369 0.421 −0.641 −0.375
p 0.195 0.000 0.000 0.000 0.000
BMI r −0.585 −0.090 −1.817 0.011 −0.104
p 0.000 0.000 0.000 0.000 0.000
BPG r −0.332 −0.035 −0.612 −0.006 −0.059
p 0.027 0.664 0.196 0.344 0.383
TG r −0.682 −0.126 −3.087 0.033 −0.103
p 0.000 0.082 0.000 0.000 0.093
TC r 0.249 −0.212 0.871 −0.017 0.213
p 0.142 0.019 0.102 0.028 0.005
*Spearman’s Correlation Coefficient. T testosterone, LH luteinizing hormone
(LH), SHBG sex hormone binding globulin, FTI free testosterone index, TSI
testosterone secretion index, BMI body mass index, BPG diphosphoglycerate,
TG triglyceride, TC total cholesterol
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recruited from the background population, and found that
reference intervals of total T (TT) in healthy young men
(11.7–37.7 nmol/l) were comparable to those observed in
healthy, elderly men (11.2–37.8 nmol/l), but reference in-
tervals for free testosterone (FT) and bioavailable testos-
terone (BT) were lower in elderly men due to higher levels
of SHBG. Yeap et al. [26] found that TT did not decline
with advancing age (aged 70–89, n = 3645). Halmenschla-
ger et al. [27] (n =428) reported not only was decreased in
TT with advancing years, but also was increased in vari-
ance later in life. Frost et al. [25], Boyce et al. [28] and
Orwoll et al. [29] (n = 783, 266, 2,623 respectively)
reported not only was there no decline in serum TT with
advancing age but also no increase in variance. Rhoden et
al. [30] reported that not only did serum TT not fall with
advancing age, but there was also an increase in variance
across the lifespan from age 40 onwards (n =1,071). Kelsey
TW et al. [31] analyzed a dataset obtained from 13 studies
(n = 10,097; age range 3–101 years), and found no evi-
dence to support a progressive decline in testosterone in
middle aged and older men.
Consistently, the current study also found that serum
total testosterone levels were relatively stable with slight
fluctuation between the age groups by 5-year apart from
20 ~ 87 years old, and that correlation analysis indicated
that there was no correlation between age and total tes-
tosterone level. In contrast, BMI was inversely and
significantly correlated with serum T level, suggesting
that measurement of total T should be interpreted in
concert with factors such as an assessment of health sta-
tus and body composition rather than simply age. Rela-
tive stable status of total testosterone found by us and
many other investigators may be due to a decline in the
number and ability of Leydig cells leading to gradual de-
cline of the serum androgen levels, which in turn
renders the hypothalamic pituitary secrete more LH and
results in stimulating T synthesis by tests. In addition,
along with the increase of age, the serum LH and SHBG
levels gradually increase, which may contribute to
gradual decline of FTI and TSI.
Correlation between body mass index (BMI) and
serum level of total and free testosterone in healthy men
has been reported by Diaz-Arjonilla et al. [5] and it was
found that the serum total and free testosterone was sig-
nificantly and inversely related to increasing BMI (r = −
0.32, p < 0.001 for total; r = − 0.45, p < 0.003 for free testos-
terone). Consistent with this report, while aging was not
significantly correlated with the alteration of total testoster-
one level in the current study, body mass index (BMI) was
negatively and significantly correlated to the levels of testos-
terone, LH, SHBG, and TSI. In addition, BPG and TG, but
not TC, were significantly and negatively correlated to total
T level. While the mechanism of negative correlation of
BMI and total testosterone remains to be defined, it has
been explained, at least in part, by lower sex hormone-
binding globulin (SHBG) in obsess men [4]. Studies also
indicated that the relationship between androgens and
BMI is likely bi-directional. In this content, on one hand,
morbid obesity has negative effects on the hypothalamic-
pituitary-gonadal axis in men [32], and on the other hand,
low testosterone levels predispose to central and visceral
adiposity [33, 34]. These findings suggest that body weight
may be a key contributor in modulating serum testoster-
one level.
Taken together, the current study demonstrated that
serum total testosterone level was relatively stable with
aging in healthy Chinese male; level of LH and SHBG
gradually increased with aging and were correlated with
age; while free testosterone index (FTI) and testosterone
secretion index (TSI) gradually decreased with aging and
were negatively correlated with age. While aging was not
significantly related to serum level of total testosterone,
body mass index was significantly and inversely corre-
lated to the serum testosterone level.
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